Somru BioScience Inc.: federal grants and contributions: 32 agreements; $10.2M value; 4 departments; 16 programs.
Assay record ASY-CA-069LYLV0EJ · Cite as: Assay Systems, “Somru BioScience Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/somru-bioscience-inc/
Development and validation of biosimilar solutions
Purchase equipment for expansion of service offerings
As part of the international consortium project “SomruAdvPAT: Development of innovative real-time analytical platform combined with AI for Intelligent Process Automation to support biomanufacturing”, this project aims to revolutionize biologics manufacturing by developing innovative near real-time Process Analytical Technology (PAT) platforms integrated with AI-driven data analytics.
Expand biomanufacturing capabilities to reduce tariff impact
Expansion of current facility to support new service offerings
Somru Bioscience Inc. has developed a library of antibodies against oncology targets. In this project we intend to sift through thousands of hits to generate leads with therapeutic potential.
Build and expand laboratory facility
Somru BioScience Inc. intends to develop fully integrated therapeutic antibody discovery platform that allows us to unlock complex targets and enable discovery of novel and rare antibodies with therapeutic potential.
The Firm intends to develop and validate a novel recombinant antibody discovery platform using a chicken immune system. This platform will allow scientists to reach into unexplored regions of protein targets (i.e. novel epitopes) by exploiting the benefits of employing a species that is phylogenetically distant from humans, thereby providing access to previously unavailable epitopes. These antibodies can be utilized for research, diagnostics and therapeutics processes.
Acquisition of equipment and development of test kits for biosimilars
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
Provide assistance to mitigate impacts of Covid-19
Engage expertise in the area of digital adoption
Hire a clinical logistics operational leader
Hire expertise to expand international markets
International Co-Innovation Action Program (ICAP) project for developing strategic plan for co-innovation and validation of drug development characterization technology.
Hire an individual for quality control and assurance
Hire specialized expertise for antibody platform development
This project is to provide support to R&D activities relating to antibodies and immunoassay processes.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
Develop and implement an effective strategy for building HVAC system optimization.
Develop and integrate method optimization and validation software for PK, ADA, Biomarker and Biosimilar assay.
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
The purpose of the Canadian International Innovation Program (CIIP) grant agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
N/A
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.